RXO, Inc. (RXO)
NYSE: RXO · Real-Time Price · USD
27.76
+0.27 (0.98%)
Nov 2, 2026, 12:21 PM EST - Market open
RXO, Inc. Revenue
RXO, Inc. had revenue of $1.87B in the quarter ending September 30, 2026, with 31.67% growth. This brings the company's total for the last twelve months to $6.54B, up 10.08% year-over-year. In the year 2025, RXO, Inc. had annual revenue of $5.74B with 26.20% growth. That makes RXO, Inc. the 2,141st largest company in the world by revenue and 629th in the United States.
Revenue (ttm)
$6.54B
Revenue Growth
+10.08%
P/S Ratio
0.69
Revenue / Employee
$946,858
Employees
6,906
Market Cap
4.58B
Revenue by Geography
- U.S. 5.34B 93.0%
- outside The U.S. 401.94M 7.0%
Fiscal year ended Dec 31, 2025 See the full RXO, Inc. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.74B | 1.19B | 26.20% |
| Dec 31, 2024 | 4.55B | 623.00M | 15.86% |
| Dec 31, 2023 | 3.93B | -869.00M | -18.12% |
| Dec 31, 2022 | 4.80B | 107.00M | 2.28% |
| Dec 31, 2021 | 4.69B | 1.33B | 39.68% |
| Dec 31, 2020 | 3.36B | 216.00M | 6.88% |
| Dec 31, 2019 | 3.14B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| XPO, Inc. | 8.83B |
| TFI International | 8.39B |
| Knight-Swift Transportation Holdings | 8.00B |
| Schneider National | 5.95B |
| ArcBest | 4.20B |
| Saia, Inc. | 3.54B |
| Werner Enterprises | 3.43B |
| Universal Logistics Holdings | 1.53B |
RXO News
- 5 hours ago - RXO Inc. price target raised to $30 from $19 at Susquehanna - TheFly
- 3 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR) - GlobeNewsWire
- 4 days ago - RXO, Inc. Earnings release: Q3 2026 - Filings
- 4 days ago - RXO, Inc. Quarterly report: Q3 2026 - Filings
- 4 days ago - RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains - Business Wire
- 13 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG) - GlobeNewsWire
- 17 days ago - C.H. Robinson price target lowered to $160 from $190 at BMO Capital - TheFly
- 26 days ago - RXO Inc. price target raised to $30 from $28 at Truist - TheFly